Alan Green talks to Venture Life Group #VLG CCO Sharon Collins about the results of the groundbreaking COVID Mouthwash trial at Cardiff University. November 17, 2020 – Posted in: Blog, Venture Life Group (VLG) – Tags: alan green, Alan Green CEO Brand Communications, alliance pharma, aph, Asda, dentyl, dentyl dual action, disinplus, Jerry Randall, kelocote, lloyds pharmacy, mermaid dentyl, novus communications CEO alan green, pharmasource, self care products, Sharon Collins, ultradex, unicorn dentyl, venture life group, vlg
Alan Green talks to Venture Life Group (AIM: VLG) CCO Sharon Collins about the results of the groundbreaking COVID Mouthwash trial at Cardiff University. Sharon also discusses the group progress to date in 2020, and summarises the current investment proposition for investors